lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
Ran Wang,1,* Xinxing Lu,2,* Riyue Yu1 1Department of Stomatology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China*These...
Main Authors: | Wang R, Lu X, Yu R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/lncrna-malat1-promotes-emt-process-and-cisplatin-resistance-of-oral-sq-peer-reviewed-article-OTT |
Similar Items
-
LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
by: Dai Q, et al.
Published: (2020-03-01) -
Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer
by: Zhao K, et al.
Published: (2018-11-01) -
lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway
by: Zhu M, et al.
Published: (2019-02-01) -
Quercetin Inhibits Epithelial-to-Mesenchymal Transition (EMT) Process and Promotes Apoptosis in Prostate Cancer via Downregulating lncRNA MALAT1
by: Lu X, et al.
Published: (2020-03-01) -
The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression
by: Kai Su, et al.
Published: (2021-05-01)